Acquisition of WaveMark is core of a new Inventory Management Solutions unit
At this week’s HIMSS meeting (Feb. 23-26), Cardinal Health announced the acquisition of WaveMark (Concord, MA), a company that has been commercializing tags, cabinets and software for tracking inventory of consumable goods in hospitals for the past decade. Jean Claude Saghbini, former CTO of Wavemark, will become GM of the newly formed Cardinal Health Inventory Management Solutions (CIMS) busness.
Although not exclusively based on radio-frequency identification (RFID) technology, Wavemark’s core technology uses that form of labeling products—in this case, med-surg kits, high-end medical devices like implants and the like—with a tag that can be tracked, wirelessly and automatically, through stockrooms, storage cabinets, mobile stations and so forth, even to the point of care. Barcode technology is deployed for low-end consumables like gloves or bandages, and a “kanban” system is in place to automatically track when bins of these low-end products are consumed. A cloud-based IT platform tracks inventory, expiration dates, product movement and other parameters to enable closer control of hospital stocks and purchases. A case study for Florida Hospital (Orlando) found $1.8-million savings for nearly 7500 stockkeeping units in a year at selected care suites in the facility. Saghbini says that already, 4 of the top 10 medical device manufacturers use Wavemark technology, and it is being deployed in 40 countries.
RFID technology had its moment in the sun in pharma distribution, but a combination of cost, technology maturity and lack of uniform regulatory standards swung the industry toward barcode technology, which is now codified in the Drug Quality and Security Act (pharma can opt to use RFID, but almost no one is planning to). On a parallel track, the medical device industry is now formalizing its Universal Device Identifier (UDI) standards—also a matter of FDA policy—so that certain medical devices will be tracked at the item level. Saghbini says that CIMS will be fully compliant with the UDI directives as they are established.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.